Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2146 AL 2160

Neuroimaging Biomarkers in a Patient With Probable Psychiatric-Onset Prodromal Dementia With Lewy Bodies

Urso D, Gnoni V, De Blasi R, Anastasia A, Aarsland D, Chaudhuri Ray K, Logroscino G.

Neurology. 2022 Oct 10;99(15):654-657. doi: 10.1212/WNL.0000000000201166.

Nitrosative stress in Parkinson's disease

Stykel MG, Ryan SD.

NPJ Parkinsons Dis. 2022 Aug 11;8(1):104. doi: 10.1038/s41531-022-00370-3.

Systematic review of Mendelian randomization studies on Parkinson's disease

Kappen S, Bottigliengo D, Caliebe A, Del Greco M F, König IR.

Med Genet. 2022 Aug 12;34(2):143-150. doi: 10.1515/medgen-2022-2139. eCollection 2022 Jun.

NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson's Disease

Curtis WM, Seeds WA, Mattson MP, Bradshaw PC.

Cells. 2022 Aug 4;11(15):2416. doi: 10.3390/cells11152416.

A Literature Review of High-Tech Physiotherapy Interventions in the Elderly with Neurological Disorders

Spanakis M, Xylouri I, Patelarou E, Patelarou A.

Int J Environ Res Public Health. 2022 Jul 28;19(15):9233. doi: 10.3390/ijerph19159233.

Research Progress of Music Therapy on Gait Intervention in Patients with Parkinson's Disease

Wu Z, Kong L, Zhang Q.

Int J Environ Res Public Health. 2022 Aug 4;19(15):9568. doi: 10.3390/ijerph19159568.

An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects

Egbujor MC, Buttari B, Profumo E, Telkoparan-Akillilar P, Saso L.

Int J Mol Sci. 2022 Jul 30;23(15):8466. doi: 10.3390/ijms23158466.

Clickable Biomaterials for Modulating Neuroinflammation

Cornelison C, Fadel S.

Int J Mol Sci. 2022 Jul 31;23(15):8496. doi: 10.3390/ijms23158496.

Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving

Haas J, Berg D, Bosy-Westphal A, Schaeffer E.

Nutrients. 2022 Aug 8;14(15):3240. doi: 10.3390/nu14153240.

Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review

Aborode AT, Pustake M, Awuah WA, Alwerdani M, Shah P, Yarlagadda R, Ahmad S, Silva Correia IF, Chandra A, Nansubuga EP, Abdul-Rahman T, Mehta A, Ali O, Amaka SO, Zuñiga YMH, Shkodina AD, Inya OC, Shen B, Alexiou A.

Oxid Med Cell Longev. 2022 Jul 31;2022:7934442. doi: 10.1155/2022/7934442. eCollection 2022.

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease

Guo M, Ji X, Liu J.

Front Aging Neurosci. 2022 Jul 26;14:919343. doi: 10.3389/fnagi.2022.919343. eCollection 2022.

Effect of Wearable Sensor-Based Exercise on Musculoskeletal Disorders in Individuals With Neurodegenerative Diseases: A Systematic Review and Meta-Analysis

Li X, Chen Z, Yue Y, Zhou X, Gu S, Tao J, Guo H, Zhu M, Du Q.

Front Aging Neurosci. 2022 Jul 26;14:934844. doi: 10.3389/fnagi.2022.934844. eCollection 2022.

Physical Therapy for at Least 6 Months Improves Motor Symptoms in Parkinson's Patients: A Meta-Analysis

Ji X, Lu D, Yang Q, Xiao L, Wang J, Wang G.

Comput Math Methods Med. 2022 Jul 31;2022:3393191. doi: 10.1155/2022/3393191. eCollection 2022.

Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?

Li D, Ren T, Li H, Liao G, Zhang X.

Front Neurol. 2022 Jul 26;13:945523. doi: 10.3389/fneur.2022.945523. eCollection 2022.

Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease

Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M, Domange C, Biere AL, Bani M, Carson S, Genius J.

Mov Disord. 2022 Oct;37(10):2045-2056. doi: 10.1002/mds.29170. Epub 2022 Aug 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias